People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · AI / ML, Biotechnology, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PAIGE.AI, Inc. | — | AI / ML | Series C | $145.5M | $316.1M | 2019 |
| AbbraTech Holdings LLC | — | Biotechnology | Series A | $8.5M | $59.4M | 2023 |
| Sentonix, Inc. | — | Pharmaceuticals | Series A | $6.5M | $30.2M | 2024 |
| Young Turks, LLC | — | Other | Seed | $3.3M | $60.4M | 2015 |
Kenan Turnacioglu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kenan Turnacioglu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 1 | 18 |
| Thomas Kelly | 1 | 9 |
| Sean Cassidy | 1 | 7 |
| Robert Galvin | 1 | 5 |
| Michael Weiner | 1 | 5 |
| Jeffrey Lightcap | 1 | 5 |
| John Beaver | 1 | 4 |
| Michael Egholm | 1 | 3 |
| Alex Robertson | 1 | 3 |
| Jim Breyer | 1 | 3 |
| David Castelblanco | 1 | 2 |
| Jack Hoppin | 1 | 2 |
| R. Martin Chavez | 1 | 2 |
| Sean Mackay | 1 | 2 |
| Norman Selby | 1 | 2 |
| Steve Oh | 1 | 1 |
| David Koller | 1 | 1 |
| Peter Andrew Hamilton | 1 | 1 |
| David Andrew Klimstra | 1 | 1 |
| Eli Andrew Casdin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.